SynthesisDiabetes, obesity & metabolism2026

Glucagon-like peptide-1 receptor agonist treatment reduces body weight and improves glycaemic outcomes in patients with concurrent overweight/obesity and type 1 diabetes: A systematic review and meta-analysis.

Amanda R Purcell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.